These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Emerging technologies for electronic monitoring of adherence, inhaler competence, and true adherence. Pritchard JN, Nicholls C. J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):69-81. PubMed ID: 25548863 [Abstract] [Full Text] [Related]
4. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Respir Med; 2013 Oct; 107(10):1481-90. PubMed ID: 23643487 [Abstract] [Full Text] [Related]
9. New nebulizer technology to monitor adherence and nebulizer performance in cystic fibrosis. McCormack P, Southern KW, McNamara PS. J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):307-9. PubMed ID: 22856641 [Abstract] [Full Text] [Related]
10. Improving the efficacy of inhaled drugs in cystic fibrosis: challenges and emerging drug delivery strategies. d'Angelo I, Conte C, La Rotonda MI, Miro A, Quaglia F, Ungaro F. Adv Drug Deliv Rev; 2014 Aug; 75():92-111. PubMed ID: 24842473 [Abstract] [Full Text] [Related]
11. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Greally P, Whitaker P, Peckham D. Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602 [Abstract] [Full Text] [Related]
12. [Inhaled therapies for cystic fibrosis]. Lahzami S, Nicod LP. Rev Med Suisse; 2011 Nov 23; 7(318):2285-8. PubMed ID: 22400363 [Abstract] [Full Text] [Related]
13. Breathing easier: addressing the challenges of aerosolizing medications to infants and preschoolers. Goralski JL, Davis SD. Respir Med; 2014 Aug 23; 108(8):1069-74. PubMed ID: 25012949 [Abstract] [Full Text] [Related]
14. "Trying, But Failing" - The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence. Braido F, Chrystyn H, Baiardini I, Bosnic-Anticevich S, van der Molen T, Dandurand RJ, Chisholm A, Carter V, Price D, Respiratory Effectiveness Group. J Allergy Clin Immunol Pract; 2016 Aug 23; 4(5):823-32. PubMed ID: 27587316 [Abstract] [Full Text] [Related]
15. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev-K M, Borowitz D, Bowman CM, Marshall BC, Marshall S, Smith AL. N Engl J Med; 1999 Jan 07; 340(1):23-30. PubMed ID: 9878641 [Abstract] [Full Text] [Related]
16. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Capstick TG, Clifton IJ. Expert Rev Respir Med; 2012 Feb 07; 6(1):91-101; quiz 102-3. PubMed ID: 22283582 [Abstract] [Full Text] [Related]
17. Nebulized therapy. SEPAR year. Olveira C, Muñoz A, Domenech A. Arch Bronconeumol; 2014 Dec 07; 50(12):535-45. PubMed ID: 24997131 [Abstract] [Full Text] [Related]
18. Technological and behavioral strategies to reduce treatment burden and improve adherence to inhaled antibiotics in cystic fibrosis. Geller DE, Madge S. Respir Med; 2011 Dec 07; 105 Suppl 2():S24-31. PubMed ID: 22208547 [Abstract] [Full Text] [Related]
19. Nebuliser systems for drug delivery in cystic fibrosis. Daniels T, Mills N, Whitaker P. Paediatr Respir Rev; 2013 Jun 07; 14(2):98-9. PubMed ID: 23583049 [No Abstract] [Full Text] [Related]
20. Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis. McNamara PS, McCormack P, McDonald AJ, Heaf L, Southern KW. J Cyst Fibros; 2009 Jul 07; 8(4):258-63. PubMed ID: 19447080 [Abstract] [Full Text] [Related] Page: [Next] [New Search]